Fournier Gangrene Clinical Trial
Official title:
Fournier's Gangrene: Seven Years of Experience in the Emergencies Service of Visceral Surgery at Ibn Rochd UHC
Case series with retrospective data collection of patients treated for Fournier's gangrene between January 2010 and March 2017. The main etiologies, risk factors, postoperative complications outcomes and long term follow up results were analyzed.
Eight four (84) patients were recruited. The average age of our patients was 49 years (with limits of 20 to 76), the male gender dominates our series (83.33%) with a sex ratio of 5M / 1W, the most frequently found risk factor was diabetes mellitus (37%). The most common etiology was anal abscesses (32%). The average time to consultation was 8 days (limits ranges from 3 to 30 days). All patients were admitted at a necrosis stage (100%). Anemia was identified in 85% of cases. The low platelets were noticed in 44.03% of cases. Hypoalbuminemia was found in 93% of cases. All patients (100%) benefited resuscitation initially and antibiotic therapy on their admission. They received emergency surgical debridement with a cleansing stoma. The average length of hospital stay was 13 days and complications occurred in 33% of cases. The mortality rate was 7.14%. then we conclude that Fournier's gangrene is a medico-surgical emergency with a high morbidity and mortality rate. Early diagnosis as well as antibiotic therapy and the quality of debridement save the patients. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05116956 -
SKin and Soft Tissue Necrotizing INfections in the Intensive Care Unit: a Prospective Multi-national Cohort Study
|
||
Completed |
NCT04694053 -
Fournier's Gangrene in Patient With Uncontrolled Type 2 Diabetes
|
||
Completed |
NCT03443544 -
Fournier's Gangrene and the Origin of the Infection as a Prognostic of Morbidity and Mortality, an Analysis of 121 Patients
|
N/A | |
Completed |
NCT05529628 -
The Immunological Differences Between Fournier Gangrene and Perianal Abscess
|
||
Completed |
NCT02180906 -
Biomarkers in Patients With Flesh-eating Bacterial Infections
|
N/A | |
Completed |
NCT02501382 -
Modulation of Biomarkers in Patients With Flesh-eating Bacterial Infections After With Hyperbaric Oxygen Treatment
|
||
Completed |
NCT03147352 -
Prognosis and Treatment of Necrotizing Soft Tissue Infections: A Prospective Cohort Study
|
||
Completed |
NCT02111161 -
Immunoglobulin for Necrotizing Soft Tissue Infections: a Randomised Controlled Trial
|
Phase 2 |